Press release
United States Breast cancer therapeutics market 2025: Industry Developments, Future Growth, Share & Industry Insights | Genentech USA, Inc, Pfizer Inc, Novartis Pharmaceuticals Inc, AstraZeneca, Eli Lilly Inc
Breast cancer therapeutics market - DataM Intelligence
DataM Intelligence has published a new research report on "Breast Cancer Therapeutics Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/breast-cancer-therapeutics-market?sg
Key Players: Genentech USA, Inc., Pfizer Inc., Novartis Pharmaceuticals Inc., AstraZeneca, Eli Lilly Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., and GSK
Industry Latest News 2025
✅ 13 Jan 2025 - Eli Lilly to acquire Scorpion Therapeutics (STX-478 PI3Kα program) - up to $2.5B (upfront + milestones). Transaction buys a PI3Kα programme that's being developed for breast cancer and other solid tumours; Scorpion will spin out non-PI3K assets.
✅ 17 Jan 2025 - FDA approves DATROWAY® (datopotamab deruxtecan) for unresectable/metastatic HR-positive, HER2-negative breast cancer after endocrine-based therapy + chemotherapy. (TROP-2 directed ADC; expands ADC options in HR+/HER2- disease).
✅ 27 Jan 2025 - FDA approves ENHERTU® (fam-trastuzumab deruxtecan-nxki) for unresectable/metastatic HR-positive, HER2-low and HER2-ultralow breast cancer after progression on endocrine therapy. (Approval based on DESTINY program data; includes companion diagnostic).
✅ 04 Apr 2025 - European Commission / EMA grants marketing authorisation for DATROWAY® (datopotamab deruxtecan) in the EU for previously-treated HR+/HER2- breast cancer. (EU product information / EPAR published).
✅ 21 Mar 2025 - AstraZeneca enters a global strategic collaboration with Harbour BioMed (multi-billion milestone potential) to discover/develop next-generation therapeutic antibodies (oncology focus). (Large partnership that furthers antibody and multi-specific programmes relevant to oncology drug discovery including breast cancer targets).
✅ June 2025 (ASCO / scientific meeting coverage) - Multiple breast-cancer trial readouts and combination data presented (ADCs, HER2-low strategies, endocrine+targeted combos), shaping near-term label/launch and trial strategies.
Growth Forecast Projected:
The Global Breast Cancer Therapeutics Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Breast Cancer Therapeutics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=breast-cancer-therapeutics-market?sg
Key Segments:
By Therapy (Chemotherapy, Hormonal Therapy, Immunotherapy, Targeted Therapy, Radiation Therapy, Surgery),
By Routes of Administration (Intravenous, Oral Route, Subcutaneous (SC) Route, Other Routes)
By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies)
Regional Analysis for Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.
Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.
Chapter 3: Offers an in-depth look at the competitive landscape among Breast Cancer Therapeutics producers, including revenue shares, strategic moves, and recent mergers and acquisitions.
Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.
Chapters 5 & 6: Analyze Breast Cancer Therapeutics revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.
Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.
Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.
Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.
Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/breast-cancer-therapeutics-market?sg
FAQ's
Q1: What is the current size of the Breast Cancer Therapeutics Market?
A: The Breast Cancer Therapeutics Market stood at US$ 37.75 Billion in 2024 and is set to experience remarkable growth, reaching US$ 72.05 Billion by 2033
Q2: How fast is the Breast Cancer Therapeutics Market growing?
A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 9.4% from 2025-2033
Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/breast-cancer-therapeutics-market?sg
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Breast cancer therapeutics market 2025: Industry Developments, Future Growth, Share & Industry Insights | Genentech USA, Inc, Pfizer Inc, Novartis Pharmaceuticals Inc, AstraZeneca, Eli Lilly Inc here
News-ID: 4245166 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Organic Infant Formula Market to Grow at 6.3% CAGR, Reaching USD 36.04 Billion b …
The global Organic Infant Formula Market reached USD 22,110 million in 2024 and is projected to reach USD 36,046 million by 2032, growing at a CAGR of 6.3% during the forecast period 2025-2032, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In October 2025, Abbott Laboratories launched a new USDA-certified organic infant formula with novel probiotic strains for enhanced gut health.
✅ In October 2025, the FDA introduced stricter…
CMO Or CDMO Biotechnology Market to hit US$ 37.53Billion by 2033 | Top Companies …
CMO/CDMO Biotechnology Market size reached US$14.32Billion in 2024 from US$12.74Billionin 2023 and is expected to reach US$ 37.53Billion by 2033, growing at a CAGR of 11.3%during the forecast period 2025-2033.
DataM Intelligence has published a new research report on "CMO-CDMO Biotechnology Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose…
Metabolic Dysfunction-Associated Steatohepatitis Drugs Market to Grow at 18.1% C …
The global Metabolic Dysfunction-Associated Steatohepatitis Drugs Market size reached USD 180.1 million in 2024 and is projected to reach USD 929.05 million by 2033, growing at a CAGR of 18.1% during the forecast period 2025-2033, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In October 2025, Madrigal Pharmaceuticals received FDA accelerated approval for resmetirom, the first targeted therapy for MASH with liver fibrosis.
✅ In October 2025, Novo…
Food Tech Market to Grow at 9.9% CAGR, Driven by Digitalization, Sustainability …
The global Food Tech Market reached USD 105.28 billion in 2024 and is projected to reach USD 224.31 billion by 2032, growing at a CAGR of 9.9% during the forecast period 2025-2032, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In October 2025, Instacart launched an AI-powered meal planning and automated grocery delivery service, integrating with smart kitchen devices.
✅ In October 2025, the FDA approved the first 3D-printed plant-based meat…
More Releases for Breast
Breast Health Monitoring App Market to Witness a Pronounce Growth during 2024-20 …
The latest market intelligence report published by WMR with the title "Global Breast Health Monitoring App Market 2024, Growth Opportunities, and Forecast" provides actionable insights on Healthcare and Pharmaceuticals industry. The report provides demand analysis, industry insights, competitive intelligence, and customer database.
The Research report on Breast Health Monitoring App Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y…
Primary Breast Cancer Survivor Phil Alderson Shines Light on Male Breast Cancer …
FOR IMMEDIATE RELEASE
Primary Breast Cancer Survivor Phil Alderson Shines Light on Male Breast Cancer During Breast Cancer Awareness Month
Liverpool, UK - October, 2023 - Phil Alderson, a primary survivor of male breast cancer, is taking bold steps this Breast Cancer Awareness Month to raise awareness of this often overlooked aspect of the disease. With a homemade cardboard sign that reads "Check Your Pecks," Phil has taken to the streets of…
Breast Health Monitoring App Market Recent Trends, In-depth Analysis, Size, and …
According to The Worldwide Market Reports, the Latest research report on "Breast Health Monitoring App Market Size, Revenue, Global Analysis, and Forecast 2023 to 2030" The Breast Health Monitoring App Market research study is a professional report with premium insights into the size of the business, current patterns, drivers, risks, potential outcomes, and major segments. The Industry Report forecasts the future growth of the market based on precise assumptions. Furthermore,…
Breast Pumps Market - Nurturing Convenience: Revolutionizing Breast Pump Technol …
Newark, New Castle, USA - new report, titled Breast Pumps Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Breast Pumps market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Breast Pumps market. The report offers an overview of the market, which…
Breast Imaging Market by Breast Ultrasound, Breast MRI, Automated Whole-Breast U …
Growth of breast imaging market driven by factors like rising incidence of breast cancer globally, growing government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities, and launch of advanced breast imaging systems capable of detecting cancer in women with dense breast tissues.
Download Free PDF Brochure on Brest Imaging Market Report Now…
Breast Implants Market Report 2018: Segmentation by Product (Silicone Breast Imp …
Global Breast Implants market research report provides company profile for Allergan, Mentor Worldwide LLC, Hans biomed, Establishment Labs, Polytech Health & Aesthetics, Sientra, Inc., GC Aesthetics, Cereplas and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to…
